Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy.
De Muro M, Janssen AJ, Amadori S, de Fabritiis P, Sabatino D, Niscola P, Torti L, Trawinska MM, Tesei C, Bombaci F, Tarricone M, Bocchia M, Fava C, Galimberti S, Iurlo A, Luciano L, Abruzzese E. De Muro M, et al. Among authors: abruzzese e. Ther Adv Hematol. 2023 Sep 6;14:20406207231190683. doi: 10.1177/20406207231190683. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37693118 Free PMC article.
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) exert their anti-proliferative activity by interfering with Akt-mTOR signaling and bax:bcl-2 ratio modulation in cells from chronic myeloid leukemic patients.
Di Stefano C, Marfe G, Trawinska MM, Sinibaldi-Salimei P, Silvestri R, Amadori S, Abruzzese E. Di Stefano C, et al. Among authors: abruzzese e. Cancer Sci. 2010 Apr;101(4):991-1000. doi: 10.1111/j.1349-7006.2010.01490.x. Cancer Sci. 2010. Retraction in: Cancer Sci. 2025 Jan;116(1):277. doi: 10.1111/cas.16390 PMID: 20704577 Free PMC article. Retracted.
Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells.
Marfe G, Di Stefano C, Gambacurta A, Ottone T, Martini V, Abruzzese E, Mologni L, Sinibaldi-Salimei P, de Fabritis P, Gambacorti-Passerini C, Amadori S, Birge RB. Marfe G, et al. Among authors: abruzzese e. Exp Hematol. 2011 Jun;39(6):653-665.e6. doi: 10.1016/j.exphem.2011.02.013. Epub 2011 Mar 8. Exp Hematol. 2011. PMID: 21392556 Free article.
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia.
Tiribelli M, Latagliata R, Luciano L, Castagnetti F, Gozzini A, Cambrin GR, Annunziata M, Stagno F, Pregno P, Albano F, Abruzzese E, Musto P, Montefusco E, Fava C, Fanin R, Pane F, Rosti G, Breccia M, Alimena G, Vigneri P. Tiribelli M, et al. Among authors: abruzzese e. Ann Hematol. 2013 Jan;92(2):179-83. doi: 10.1007/s00277-012-1591-2. Epub 2012 Oct 10. Ann Hematol. 2013. PMID: 23053188
Dysgeusia in patients with hematological malignancies: a reminder for hematologist.
Tendas A, Niscola P, Scaramucci L, Giovannini M, Cupelli L, Trawinska MM, Siniscalchi A, Abruzzese E, Caravita T, Palombi M, Dentamaro T, Perrotti A, de Fabritiis P. Tendas A, et al. Among authors: abruzzese e. J Oral Pathol Med. 2013 Apr;42(4):352-3. doi: 10.1111/jop.12034. Epub 2012 Dec 21. J Oral Pathol Med. 2013. PMID: 23278835 No abstract available.
218 results